Trademark: 90532969
Word
PILLAR BIOSCIENCES
Status
Registered
Status Code
700
Status Date
Tuesday, February 28, 2023
Serial Number
90532969
Registration Number
6992395
Registration Date
Tuesday, February 28, 2023
Mark Type
5000
Filing Date
Wednesday, February 17, 2021
Published for Opposition
Tuesday, May 10, 2022

Trademark Owner History
Pillar Biosciences, Inc. - Original Registrant

Classifications
9 Downloadable computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; downloadable computer software for analyzing biological samples; downloadable computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; downloadable computer software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; downloadable computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; downloadable computer software for health and wellness assessment, namely, for use in genomic analysis; downloadable computer software for genetic and bioinformatics analysis
5 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical diagnostic purposes; biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer; biological and biochemical kits for medical diagnostic purposes
35 Data processing services for medical, clinical, and scientific purposes
1 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research; biological and biochemical kits for scientific research, clinical research, and scientific diagnostics research
44 Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics; medical testing for diagnostic and treatment purposes; health and wellness assessment services; providing health and wellness information
42 Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; software as a service (SaaS), namely, hosting non-downloadable computer software for health and wellness assessment, namely, for genomic analysis; software as a service (SaaS), namely, hosting non-downloadable computer software for genetic and bioinformatics analysis; bioinformatics services, namely, product research and development in the field of bioinformatics; developing diagnostic testing models for others for medical, clinical, and scientific purposes; genetic testing for scientific research purposes; scientific research consulting
The mark consists of the word "PiLLAR" in large bold lettering with a stylized letter "I" above the word "BIOSCIENCES", shown in all capital letters and fine print.
"BIOSCIENCES"

Trademark Events
Feb 28, 2023
Notice Of Registration Confirmation Emailed
Feb 28, 2023
Registered-Principal Register
Jan 27, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 26, 2023
Allowed Principal Register - Sou Accepted
Jan 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 19, 2023
Statement Of Use Processing Complete
Jan 19, 2023
Sou Extension 1 Granted
Jan 4, 2023
Sou Extension 1 Filed
Jan 4, 2023
Use Amendment Filed
Jan 19, 2023
Case Assigned To Intent To Use Paralegal
Jan 4, 2023
Teas Extension Received
Jan 4, 2023
Teas Statement Of Use Received
Oct 27, 2022
Teas Change Of Correspondence Received
Oct 27, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 27, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 27, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 5, 2022
Noa E-Mailed - Sou Required From Applicant
May 10, 2022
Official Gazette Publication Confirmation E-Mailed
May 10, 2022
Published For Opposition
Apr 20, 2022
Notification Of Notice Of Publication E-Mailed
Apr 7, 2022
Law Office Publication Review Completed
Apr 4, 2022
Assigned To Lie
Mar 31, 2022
Approved For Pub - Principal Register
Mar 22, 2022
Teas/Email Correspondence Entered
Mar 21, 2022
Correspondence Received In Law Office
Mar 21, 2022
Teas Response To Office Action Received
Sep 21, 2021
Notification Of Non-Final Action E-Mailed
Sep 21, 2021
Non-Final Action E-Mailed
Sep 21, 2021
Non-Final Action Written
Sep 11, 2021
Assigned To Examiner
May 19, 2021
New Application Office Supplied Data Entered
Feb 23, 2021
Teas Amendment Entered Before Attorney Assigned
Feb 23, 2021
Teas Voluntary Amendment Received
Feb 20, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24